• Citer

A phase i dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer

par Coombes, Charles R.C.;Cardoso, Fatima ;Isambert, Nicolas;Lesimple, Thierry;Soulié, Patrick;Peraire, Concepcion;Fohanno, Veronique;Kornowski, Anne;Ali, Tauhid;Schmid, Peter
Référence Breast cancer research and treatment, 140, 1, page (73-82)
Publication Publié, 2013-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	A phase i dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
Auteur:	Coombes, Charles R.C.; Cardoso, Fatima; Isambert, Nicolas; Lesimple, Thierry; Soulié, Patrick; Peraire, Concepcion; Fohanno, Veronique; Kornowski, Anne; Ali, Tauhid; Schmid, Peter
Informations sur la publication:	Breast cancer research and treatment, 140, 1, page (73-82)
Statut de publication:	Publié, 2013-07
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Dose escalation
	Irosustat
	Steroid sulfatase inhibitor
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-013-2597-8
	info:scp/84880263048